Over 450 student teams competed in an annual international robotics competition in Houston last weekend. Photo by Argenis Apolinario/FIRST

Adolescents from 40-plus countries convened in Houston to put their robotic skills to test at the annual FIRST Championship last week.

The massive robotics championship returned this year to the George R. Brown to conclude the 2021-22 season of the international program, which is aimed at preparing youth ages 12 to 18 for the future through various robotics challenges and competitions.

The theme of this year’s season was FIRST FORWARD, in which students were challenged to think of new ways to overcome transportation challenges, “from the shipment of packages in rural and urban areas, to disaster relief delivery and high-tech space transit,” according to a release from the STEM organization.

The season was sponsored by California-based semiconductor company Qualcomm and was inspired in part by the UN Sustainable Development Goal of building resilient infrastructure, promoting inclusive and sustainable industrialization, and fostering innovation, according to the statement.

“I have met so many great students, volunteers, mentors, alumni, and sponsors who truly embody the FIRST mission and core Values," FIRST CEO Chris Moore says in a statement after the event. "People who strive to be gracious professionals who innovate, compete, and collaborate with equal energy. People who share our common passion for science and technology as a force for good with the world. The rewards of your efforts don’t stop at this event.”

Teams competed in final matches for FIRST's two major competitions.

In the FIRST Robotics Competition, which featured the RAPID REACT Game presented by Boeing, students were required to reimagine the future of his-speed transport with strict rules, limited resources, and time limits and using autonomous and driver-operated skills.

More than 3,200 teams competed during this game throughout the 2002 FIRST season and 454 teams advanced to the championship at the GRB. Team 1629 from Accident, Maryland, took home the top prize in this competition. Other teams from Austin, New York, Hawaii, Mexico, and Turkey were finalists.

In the FIRST Tech Challenge, teams were asked to think like engineers, building robots from reusables kits in the game FREIGHT FRENZY presented by Raytheon Technologies. Thousands of teams competed in this event throughout the season with 160 teams advancing to Houston. Team 8565 (the TechnicBots) from Plano won the top award.

A FIRST LEGO League challenge was also open to younger students, ages 4 to 16, and the championship. Also during the event, actress and director Gillian Jacobs accepted an award for the film "More Than Robots," which follows four teams as they prepare for the 2020 FIRST competition. The film premiered at SXSW last month and is featured on Disney+.

“I named this documentary ‘More Than Robots’ because as you all well know better than anyone, FIRST is about so much more than robots. I learned that it's about teamwork, compassion, friendship, learning new skills, and challenging yourself to do things you never dreamed you were capable of," Jacobs said at the event.

FIRST's 2022-23 season, dubbed FIRST ENERGIZE, will focus on innovative energy solutions. The season opens in May. Learn more here.

The theme of this year’s season was FIRST FORWARD, in which students were challenged to think of new ways to overcome transportation challenges. Photo by Argenis Apolinario/FIRST

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”